Chiara Calore

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Pattern of use of conventional medical treatments of heart failure with reduced ejection fraction in end-stage hypertrophic cardiomyopathy.

Pattern of use of conventional medical treatments of heart failure with reduced ejection fraction in end-stage hypertrophic cardiomyopathy.

Journal: International journal of cardiology

Published: April 22, 2026

Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.

Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.

Journal: International journal of cardiology

Published: July 30, 2025

The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.

The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: February 21, 2025

Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology.

Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology.

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: January 22, 2025

Hypertrophic Cardiomyopathy: New Clinical and Therapeutic Perspectives of an "Old" Genetic Myocardial Disease.

Hypertrophic Cardiomyopathy: New Clinical and Therapeutic Perspectives of an "Old" Genetic Myocardial Disease.

Journal: Genes

Published: November 30, 2024

Storytelling of Hypertrophic Cardiomyopathy Discovery.

Storytelling of Hypertrophic Cardiomyopathy Discovery.

Journal: Journal of cardiovascular development and disease

Published: July 04, 2024

Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations.

Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations.

Journal: Journal of neurology

Published: July 02, 2024

The "Padua classification" of cardiomyopathies: Combining pathobiological basis and morpho-functional remodeling.

The "Padua classification" of cardiomyopathies: Combining pathobiological basis and morpho-functional remodeling.

Journal: International journal of cardiology

Published: May 16, 2024

The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.

The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.

Journal: Journal of neuromuscular diseases

Published: February 16, 2024

Causes of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in children.

Causes of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in children.

Journal: British journal of sports medicine

Published: January 01, 2024

Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population.

Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population.

Journal: European journal of heart failure

Published: October 20, 2023

Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.

Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.

Journal: International journal of cardiology

Published: October 11, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026